I can only hope that requiring full data from the CD03 trial means that the FDA is considering approval for mono as well. Otherwise, this is a ridiculous and meaningless delay from the FDA.

Agree that cancer is the real money maker (ex NASH), but coronavirus could potentially put us in the spotlight faster than anything. Talk about getting into the mainstream view...